Lovell Dale I, Stuelcken Max, Eagles Alexander
School of Health, The University of the Sunshine Coast, Maroochydore, QLD, 4556, Australia.
Timeless Medical Australia, Maroochydore, QLD, 4556, Australia.
Eur J Appl Physiol. 2025 Jul 3. doi: 10.1007/s00421-025-05875-2.
Cardiorespiratory fitness (CRF), assessed by maximal oxygen consumption ( O max) testing, is a strong predictor of chronic disease and all-cause mortality. However, recent evidence suggests that O max may lack specificity and sensitivity in assessing metabolic health, particularly mitochondrial function, which is associated with metabolic diseases such as type 2 diabetes, insulin resistance, and metabolic syndrome. While aerobic training leads to improvements in mitochondrial function, studies have found a disparity between O max and mitochondrial content, with some individuals showing increases in mitochondrial oxidative capacity without changes in O max. Furthermore, the criteria used to determine O max, such as the plateau in oxygen consumption, may not be achieved by all individuals, leading to inaccurate assessments. Technological advances in metabolomics and lipidomics may provide insights into metabolic health, but their cost and practicality for routine use in clinical settings remain a challenge. Alternatively, indirect calorimetry during submaximal exercise has shown promise as a non-invasive marker of mitochondrial function and metabolic flexibility. However, further research is needed to establish appropriate protocols and analyses for various populations.
通过最大摄氧量(VO₂max)测试评估的心肺适能(CRF)是慢性疾病和全因死亡率的有力预测指标。然而,最近的证据表明,VO₂max在评估代谢健康,特别是线粒体功能方面可能缺乏特异性和敏感性,而线粒体功能与2型糖尿病、胰岛素抵抗和代谢综合征等代谢性疾病相关。虽然有氧训练可改善线粒体功能,但研究发现VO₂max与线粒体含量之间存在差异,一些个体线粒体氧化能力增加,而VO₂max却无变化。此外,并非所有个体都能达到用于确定VO₂max的标准,如耗氧量平台期,这会导致评估不准确。代谢组学和脂质组学的技术进步可能为代谢健康提供见解,但其在临床环境中常规使用的成本和实用性仍然是一个挑战。另外,次最大运动期间的间接测热法已显示出有望成为线粒体功能和代谢灵活性的非侵入性标志物。然而,需要进一步研究为不同人群建立合适的方案和分析方法。